It is known that vasculopathy plays a pivotal role in the pathogenesis of systemic sclerosis (SSc). Vasoactive vasodilating drugs (VVD) are an option. The most recent treatment recommendations from EULAR—The European Alliance of Associations for […]
Adolescents and young adults with chronic diseases need special care—and pediatric rheumatological conditions can persist into adulthood. Two new works presented at the 2025 congress of EULAR—The European Alliance of Associations for Rheumatology—consider the training […]
Regular physical activity is increasingly promoted for people with rheumatic and musculoskeletal diseases (RMD) as well as the general population. EULAR—The European Alliance of Associations for Rheumatology—has published recommendations for physical activity in people with […]
Osteoarthritis is a leading cause of chronic pain, often affecting physical function, daily activities, and quality of life. EULAR—The European Alliance of Associations for Rheumatology—has developed recommendations and clinical practice guidelines for the management of […]
EULAR—The European Alliance of Associations for Rheumatology—believes that nurses are an important part of the health care team, especially for providing evidence-based care and endorsing shared decision-making in consultation with the patient. This is also […]
When receiving a diagnosis of a rheumatic musculoskeletal disease (RMD), people need a lot of information. Some need it all at once, while others may prefer to receive it in smaller portions or like to […]
Rheumatic musculoskeletal diseases (RMD) have an important impact on quality of life, and represent an economic burden to society. EULAR—The European Alliance of Associations for Rheumatology—has emphasized the role of patient empowerment through education.This article […]
Rheumatic and musculoskeletal diseases (RMD) are the leading causes of disability worldwide, resulting in significant health care and social support costs. One of the reasons for this increasing burden seems to be the variability in […]
Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an elevated risk of cancer with tofacitinib, compared to TNF inhibitors (TNFi).This article was originally published on MedicalXpress.com
Social determinants of health (SDH), such as socioeconomic status and educational background are factors that are increasingly recognized as critical contributors to health outcomes in chronic diseases. Understanding how certain factors impact different rheumatic and […]
© 2025 SimplyWell.ca